Apr. 9 at 2:26 PM
Most aesthetic medicine companies are still investing heavily to grow.
SBC Medical
$SBC is operating at scale with a 42% EBITDA margin, 283 clinics across Asia, and 6.63 million patient visits annually.
Now the company is entering the U.S. with
$127M in cash, minimal leverage, and a structured partnership with OrangeTwist, a MedSpa platform operating across multiple states.
Profitable at scale. Expanding with discipline.
#sbcmedical